Commonwealth Equity Services, LLC Hepion Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$0.57 - $1.22 $50 - $108	89 Added 0.89%	10,090 $5,000
Q1 2022 May 04, 2022	BUY	$0.93 - $1.29 $0 - $1	1 Added 0.01%	10,001 $12,000
Q4 2021 Jan 31, 2022	BUY	$1.14 - $1.58 $11,399 - $15,800	10,000 New	10,000 $11,000
Q2 2021 Aug 11, 2021	SELL	$1.56 - $2.26 $18,557 - $26,884	-11,896 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$1.77 - $2.98 $2,718 - $4,577	1,536 Added 14.83%	11,896 $21,000
Q4 2020 Feb 11, 2021	BUY	$1.58 - $3.64 $16,368 - $37,710	10,360 New	10,360 $22,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.